Indicate Solutions develops an instant, affordable blood-analysis test intended to identify cancer biomarkers and other disease indicators. The system is designed to be easy to use and to help physicians make faster clinical decisions to improve patient outcomes. The founding team includes British researcher Charles Lawrie and Javier Zubiría. The company is also exploring applying its technology to COVID-19 detection, as the platform can identify viruses. Indicate Solutions was selected by accelerator BerriUp as part of a biotech and design-focused cohort. As part of the selection, BerriUp invested and entered a support relationship that includes capital and a four-month accompaniment program.

Total raised

$54M

Funding rounds

1

Latest round

Equity

Latest activity

Apr 2020